SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is gaining attention as the 'Dogecoin of the AI Age', with community members highlighting its connection to Grok AI and Elon Musk's xAI. The community is actively engaging with the coin, using terms like 'UpDog' and noting its resilience amidst market fluctuations.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending, and the community is actively engaging with the classic 'What's UpDog?' joke, driving its visibility. Built on Solana and listed on Jupiter Strict List, this joke-meta coin has maintained a dedicated community for over a year, focusing on community and memetic appeal.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the community discusses its potential to break key resistance levels and make a parabolic move, with some anticipating a squeeze on short positions. Optimism is fueled by observations of coins leaving exchanges and a sense that the market is shifting away from altcoins. Broader conversations touch on the impact of potential government shutdowns and historical performance trends.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry ($BB.TSX) is trending amid renewed investor optimism, fueled by strong partnerships and expectations for upcoming earnings. The community is closely watching for continued growth in QNX, a key software platform, and potential revenue from existing royalty backlog.  Many believe a significant breakout is imminent, driven by the company's shift towards cybersecurity and IoT.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending due to positive Phase 2 trial results for its drug sonelokimab in treating hidradenitis suppurativa, with the community actively discussing its potential as a best-in-class treatment. Some investors speculate about a possible acquisition, while others are wary of a potential public offering. The stock's high short interest adds fuel to the conversation around its potential for significant price movement.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as the community discusses its potential breakout and accumulation at current prices, with some anticipating a significant upward move. Bullish sentiment seems to be fueled by discussions around altcoin season and NEAR's position in the AI crypto space. There's also chatter about potential partnerships and advancements in NEAR's underlying technology contributing to the positive outlook.

Doodles is a next-generation entertainment company focused on immersive storytelling through the creation and distribution of live and digital experiences, original content, and lifestyle products.  Doodles mission is to define the standard for immersive storytelling and color the world with joy.

Doodle Inu

Doodle Inu ($DOOD.X) is trending as the community rallies around its potential, with some eyeing a push towards the 50 mark and beyond.  Enthusiasm is fueled by comparisons to other meme coins and a newly launched dApp that allows users to create and upload their own Doodle Inu-themed NFTs. Some community members cite endorsements from crypto influencers and potential collaborations as further catalysts.

Blockchain-on-Blockchain (BOB) is a new blockchain built on top of another blockchain called ICP. It's like a special layer on an existing system. BOB creates a secure digital record book that uses ICP's network for safety. BOB uses a system called 'proof-of-on-chain-work': You deploy your own smart contract (canister) at bob.fun. This program solves math problems (hashes). Main computers (mother nodes) give out these problems. Miners solve the problems and tell the mother node. If correct, the mother node adds a new block to the blockchain. The winning miner gets BOB tokens as a reward.

$BOB.X is trending as discussions emerge around its limited supply and upcoming halving event, drawing comparisons to $BTC.X. The community highlights its multi-chain availability and increasing adoption within the web3 space, while some suggest it may outperform other tokens. Speculation around future price targets and potential for significant gains are also circulating.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as the community discusses its potential in real-world asset tokenization and its selection by Wyoming for its stablecoin initiative, $FRNT. Recent price action and potential ETF approvals are also sparking conversations, although some traders express frustration with HBAR.X's performance compared to meme coins.

Meet Pandu — your AI friend who’s always by your side. Talk with him in real time through text or voice, share your thoughts, ask questions, or just enjoy a casual conversation. Whether you’re looking for advice, company, or simply someone to listen, Pandu is here as a true companion you can connect with anytime.  Pandu unites real-time conversation, creative generation, and future-ready AI systems — all powered by next-gen technology.

Pandu Pandas

Pandu Pandas is trending, with community members highlighting its recent listing on MEXC and comparing it to other tokens like PENGU. Discussions revolve around potential upcoming announcements and the project's strong fundamentals. Some users are also discussing which wallets they prefer to hold PANDU.X.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor...

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Janux Therapeutics Announces Proposed Public Offering

<a href="https://stocktwits.com/symbol/JANX">Shares of Janux Therapeutics</a> Inc. surged over 54% on Tuesday afternoon, reaching levels not seen since May and breaking a five-day losing streak.&nbsp;The rally followed the company’s Monday announcement of promising Phase I trial data for its prostate cancer treatment, JANX007.In the trial, all 16 heavily pre-treated patients demonstrated a reduction of at least 50% in prostate-specific antigen (PSA) levels, a key indicator of cancer.&nbsp;The news sparked a wave of bullish analyst notes and retail investor enthusiasm.Stifel raised its price target to $115 from $70, citing increased probabilities of success for JANX007 in second- and third-line metastatic castration-resistant prostate cancer.&nbsp;The brokerage now forecasts $1.7 billion in risk-adjusted sales from these indications.&nbsp;Leerink boosted its price target to $91, highlighting the treatment’s “best-in-class” safety and efficacy profile.Cantor Fitzgerald took an even more optimistic stance, doubling its price target to $200. The brokerage praised JANX007 for achieving “unprecedented” PSA50 and PSA90 response rates while maintaining a tolerable safety profile.&nbsp;H.C. Wainwright also raised its target, albeit more modestly, to $70, increasing its probability of launch for JANX007 to 26% from 20%.<figure class="image"><a href="https://stocktwits.com/symbol/JANX"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/JANX_sentiment_and_message_volume_on_Dec_3_f914cb43e0.png" alt="JANX sentiment and message volume on Dec 3.png" width="1318" height="318"></a><figcaption>JANX sentiment and message volume on Dec 3 as of 2:15 pm ET | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits turned ‘extremely bullish’ amid a sharp increase in message volume, with many users seeing the breakthrough as a major milestone.&nbsp;The treatment, a tumor-activated T-cell engager, leverages the immune system by recruiting white blood cells to attack cancer cells.Janux has selected two once-weekly dose regimens for expansion trials targeting patients with two or three prior lines of therapy.&nbsp;The stock, up 460% year-to-date, is reportedly on track for its best year ever.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/gm-stock-dips-after-plan-to-sell-battery-plant-stake/cJ9NCvaRhn">GM Stock Suffers Despite Battery Plant Stake Sale Plan: Retail Sentiment Dips To 5-Month Low</a>

Janux's stock, up 460% year-to-date, is reportedly on track for its best year ever.

Janux Therapeutics Stock Hits 7-Month High On Prostate Cancer Drug Trial Data: Retail Confidence Spikes

The treatment, a tumor-activated T-cell engager, leverages the immune system by recruiting white blood cells to attack cancer cells.

Equity

The treatment, a tumor-activated T-cell engager, leverages the immune system by recruiting white blood cells to attack cancer cells.


Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Navigating 5 Analyst Ratings For Janux Therapeutics

Latest Ratings for JANX
 DateFirmActionFromTo Jul 2021B of A SecuritiesInitiates Coverage OnBuy Jul 2021Cowen & Co.Initiates Coverage OnOutperform Jul 2021HC Wainwright & Co.Initiates Coverage OnBuy...

Analyst Expectations For Janux Therapeutics's Future

Janux Therapeutics Announces Updates to Board of Directors

Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb

Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb PR Newswire VANCOUVER, BC, May 9, 2024 USA...

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Janux Therapeutics Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

JANX
Janux Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JANX News

JANX Janux Therapeutics Inc